Xialing Guo

Person

San Clemente, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds as tyrosine kinase modulators
- Patent number 10,221,192
- Issue date Mar 5, 2019
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-ind...
- Patent number 9,758,509
- Issue date Sep 12, 2017
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as tyrosine kinase modulators
- Patent number 9,725,433
- Issue date Aug 8, 2017
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-ind...
- Patent number 9,657,005
- Issue date May 23, 2017
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as tyrosine kinase modulators
- Patent number 9,475,801
- Issue date Oct 25, 2016
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as tyrosine kinase modulators
- Patent number 9,340,555
- Issue date May 17, 2016
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as tyrosine kinase modulators
- Patent number 9,328,103
- Issue date May 3, 2016
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as tyrosine kinase modulators
- Patent number 8,906,944
- Issue date Dec 9, 2014
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-ind...
- Patent number 8,877,923
- Issue date Nov 4, 2014
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-ind...
- Patent number 8,865,682
- Issue date Oct 21, 2014
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as tyrosine kinase modulators
- Patent number 8,809,534
- Issue date Aug 19, 2014
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as tyrosine kinase modulators
- Patent number 8,614,234
- Issue date Dec 24, 2013
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl dihydroindolones as kinase inhibitors
- Patent number 8,455,535
- Issue date Jun 4, 2013
- Allergan, Inc.
- Sougato Boral
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase inhibitors
- Patent number 8,455,656
- Issue date Jun 4, 2013
- Allergan, Inc.
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-ind...
- Patent number 8,367,664
- Issue date Feb 5, 2013
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-ind...
- Patent number 8,338,415
- Issue date Dec 25, 2012
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl dihydroindolones as kinase inhibitors
- Patent number 7,977,351
- Issue date Jul 12, 2011
- Allergan, Inc.
- Sougato Boral
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase inhibitors for the treatment of disease
- Patent number 7,531,665
- Issue date May 12, 2009
- Allergan, Inc.
- Steven W. Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones...
- Patent number 7,060,844
- Issue date Jun 13, 2006
- Allergan, Inc.
- Steven W. Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase inhibitors for the treatment of disease
- Patent number 6,747,025
- Issue date Jun 8, 2004
- Allergan, Inc.
- Steven W. Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones...
- Patent number 6,541,504
- Issue date Apr 1, 2003
- Allergan Sales, LLC
- Steven W. Andrews
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS AS TYROSINE KINASE MODULATORS
- Publication number 20180086774
- Publication date Mar 29, 2018
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...
- Publication number 20170174664
- Publication date Jun 22, 2017
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AS TYROSINE KINASE MODULATORS
- Publication number 20170066738
- Publication date Mar 9, 2017
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AS TYROSINE KINASE MODULATORS
- Publication number 20160355527
- Publication date Dec 8, 2016
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AS TYROSINE KINASE MODULATORS
- Publication number 20160090372
- Publication date Mar 31, 2016
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...
- Publication number 20150099746
- Publication date Apr 9, 2015
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...
- Publication number 20150018310
- Publication date Jan 15, 2015
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AS TYROSINE KINASE MODULATORS
- Publication number 20140336108
- Publication date Nov 13, 2014
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AS TYROSINE KINASE MODULATORS
- Publication number 20140100212
- Publication date Apr 10, 2014
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KINASE INHIBITORS
- Publication number 20130267497
- Publication date Oct 10, 2013
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...
- Publication number 20130217650
- Publication date Aug 22, 2013
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...
- Publication number 20130123259
- Publication date May 16, 2013
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AS TYROSINE KINASE MODULATORS
- Publication number 20130065880
- Publication date Mar 14, 2013
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Kinase inhibitors
- Publication number 20120238558
- Publication date Sep 20, 2012
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heteroaryl Dihydroindolones as Kinase Inhibitors
- Publication number 20110257238
- Publication date Oct 20, 2011
- Allergan, Inc.
- Sougato Boral
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AS TYROSINE KINASE MODULATORS
- Publication number 20110053973
- Publication date Mar 3, 2011
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AS TYROSINE KINASE MODULATORS
- Publication number 20110053905
- Publication date Mar 3, 2011
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Kinase inhibitors
- Publication number 20090286773
- Publication date Nov 19, 2009
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL DIHYDROINDOLONES AS KINASE INHIBITORS
- Publication number 20080045526
- Publication date Feb 21, 2008
- Sougato Boral
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...
- Publication number 20070173501
- Publication date Jul 26, 2007
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...
- Publication number 20070173500
- Publication date Jul 26, 2007
- Allergan, Inc.
- Xialing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones...
- Publication number 20060004084
- Publication date Jan 5, 2006
- Steven W. Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Kinase inhibitors for the treatment of disease
- Publication number 20040198802
- Publication date Oct 7, 2004
- Allergan, Inc.
- Steven W. Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KINASE INHIBITORS FOR THE TREATMENT OF DISEASE
- Publication number 20040102509
- Publication date May 27, 2004
- Allergan, Inc.
- Steven W. Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones...
- Publication number 20040019098
- Publication date Jan 29, 2004
- Allergan, Inc.
- Steven W. Andrews
- C07 - ORGANIC CHEMISTRY

Xialing Guo

Person

Patents Grantslast 30 patents

Compounds as tyrosine kinase modulators

Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-ind...

Compounds as tyrosine kinase modulators

Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-ind...

Compounds as tyrosine kinase modulators

Compounds as tyrosine kinase modulators

Compounds as tyrosine kinase modulators

Compounds as tyrosine kinase modulators

Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-ind...

Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-ind...

Compounds as tyrosine kinase modulators

Compounds as tyrosine kinase modulators

Heteroaryl dihydroindolones as kinase inhibitors

Kinase inhibitors

Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-ind...

Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-ind...

Heteroaryl dihydroindolones as kinase inhibitors

Kinase inhibitors for the treatment of disease

(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones...

Kinase inhibitors for the treatment of disease

(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones...

Patents Applicationslast 30 patents

COMPOUNDS AS TYROSINE KINASE MODULATORS

SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...

COMPOUNDS AS TYROSINE KINASE MODULATORS

COMPOUNDS AS TYROSINE KINASE MODULATORS

COMPOUNDS AS TYROSINE KINASE MODULATORS

SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...

SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...

COMPOUNDS AS TYROSINE KINASE MODULATORS

COMPOUNDS AS TYROSINE KINASE MODULATORS

KINASE INHIBITORS

SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...

SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...

COMPOUNDS AS TYROSINE KINASE MODULATORS

Kinase inhibitors

Heteroaryl Dihydroindolones as Kinase Inhibitors

COMPOUNDS AS TYROSINE KINASE MODULATORS

COMPOUNDS AS TYROSINE KINASE MODULATORS

Kinase inhibitors

HETEROARYL DIHYDROINDOLONES AS KINASE INHIBITORS

SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...

SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-IND...

(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones...

Kinase inhibitors for the treatment of disease

KINASE INHIBITORS FOR THE TREATMENT OF DISEASE

(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones...